Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: VOLUME

"What financial info have you seen?...."

I forget where I saw it, but I saw something showing that Crossflo owed it's previous (to us) shareholders a lot of money. I don't remember exactly how much but remember thinking that is was close to what we were paying for Crossflo - $10 million.

Because fo this debt, and because Crossflo is in a business that doesn't require a tremendous amount of money to be invested in hard/fixed assets, I assume that this debt was due to loans needed fund operations that were losing money. I could be wrong, but I would say chances are that I am right. The Crossflo financials, when filed with the SEC, will answer this question.

"You dont think this information will give you an idea of where Crossflo stands as an operating company??"

I don't think the Crossflo info will give you any insight as to why they were worth the $10 million we paid for them. We paid for the future, not the past. Again, I think they've lost money in the past. So it will be hard to understand why they are worth $10 million unless you get insight into how they will turn profitable - a question that is usually answered as an increase in revenues. That, IMO, will not be overtly apparent in the filing of historical financial statements.

Share
New Message
Please login to post a reply